UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 149 filers reported holding UNIQURE NV in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $268,000 | -22.3% | 12,924 | +19.8% | 0.51% | +11.1% |
| Q3 2021 | $345,000 | +3.9% | 10,787 | +9.4% | 0.46% | +41.1% |
| Q1 2021 | $332,000 | +37.2% | 9,857 | +47.1% | 0.33% | +26.4% |
| Q4 2020 | $242,000 | -43.3% | 6,700 | -42.2% | 0.26% | +15.7% |
| Q3 2020 | $427,000 | +39.1% | 11,600 | +70.1% | 0.22% | +8.8% |
| Q2 2020 | $307,000 | -3.2% | 6,821 | +1.9% | 0.20% | -14.2% |
| Q1 2020 | $317,000 | -26.3% | 6,691 | +11.4% | 0.24% | +0.4% |
| Q4 2019 | $430,000 | -28.2% | 6,007 | -21.7% | 0.24% | -42.0% |
| Q2 2019 | $599,000 | – | 7,670 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |